Volume of Distribution Prediction

Volume of distribution prediction estimates tissue drug distribution extent informing dose calculations. Binding to plasma proteins reduces apparent volume. Tissue binding increases distribution volume. Lipophilicity correlates with volume extent. Population differences explain interindividual variation.

Regulatory submissions justify volume predictions. Bioanalytical confirmation measures actual distribution. Population pharmacokinetics account for variability. Therapeutic drug monitoring refines predictions. Post-approval monitoring confirms predicted distributions.